Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,253 | -7,846 | -5,356 | -2,122 | -10,650 |
| Depreciation Amortization | 60 | 32 | 18 | 6 | 20 |
| Other Working Capital | 442 | 1,041 | 336 | 363 | -70 |
| Other Operating Activity | 714 | 422 | 397 | 0 | 600 |
| Operating Cash Flow | $-9,037 | $-6,352 | $-4,606 | $-1,752 | $-10,100 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -541 | -223 | -175 | -175 | -40 |
| Purchase Of Investment | -6,606 | -6,180 | -2,621 | -2,621 | -20,511 |
| Sale Of Investment | 16,066 | 14,735 | 10,542 | 6,928 | 16,413 |
| Other Investing Activity | -2 | 1 | -7 | -3 | -2 |
| Investing Cash Flow | $8,917 | $8,333 | $7,739 | $4,129 | $-4,140 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 14,477 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -87 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $14,390 |
| Beginning Cash Position | 407 | 407 | 407 | 407 | 260 |
| End Cash Position | 287 | 2,389 | 3,540 | 2,784 | 400 |
| Net Cash Flow | $-120 | $1,981 | $3,133 | $2,377 | $140 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,037 | -6,352 | -4,606 | -1,752 | -10,100 |
| Capital Expenditure | -541 | -223 | -175 | -175 | -44 |
| Free Cash Flow | -9,578 | -6,575 | -4,781 | -1,927 | -10,144 |